SeaStar Medical Holding Corporation – NASDAQ:ICUCW
SeaStar Medical Holding stock price today
SeaStar Medical Holding stock price monthly change
SeaStar Medical Holding stock price quarterly change
SeaStar Medical Holding stock price yearly change
SeaStar Medical Holding key metrics
Market Cap | 7.11M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -1.07 |
Revenue | N/A |
EBITDA | -13.43M |
Income | -33.66M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSeaStar Medical Holding stock price history
SeaStar Medical Holding stock forecast
SeaStar Medical Holding financial statements
| Jun 2023 | 0 | -3.66M | |
|---|---|---|---|
| Sep 2023 | 0 | -7.42M | |
| Dec 2023 | 0 | -9.87M | |
| Mar 2024 | 0 | -12.69M |
| Jun 2023 | 2334000 | 13.78M | 590.49% |
|---|---|---|---|
| Sep 2023 | 2247000 | 18.15M | 807.74% |
| Dec 2023 | 3513000 | 17.38M | 494.82% |
| Mar 2024 | 7740000 | 12.21M | 157.79% |
| Jun 2023 | -2.16M | 0 | 1.45M |
|---|---|---|---|
| Sep 2023 | -1.33M | 0 | 1.39M |
| Dec 2023 | -4.48M | 0 | 4.58M |
| Mar 2024 | -3.48M | 0 | 8.33M |
SeaStar Medical Holding alternative data
| Aug 2023 | 3 |
|---|---|
| Sep 2023 | 3 |
| Oct 2023 | 3 |
| Nov 2023 | 3 |
| Dec 2023 | 3 |
| Jan 2024 | 9 |
| Feb 2024 | 9 |
| Mar 2024 | 9 |
| Apr 2024 | 9 |
| May 2024 | 12 |
| Jun 2024 | 12 |
| Jul 2024 | 12 |
SeaStar Medical Holding other data
-
What's the price of SeaStar Medical Holding stock today?
One share of SeaStar Medical Holding stock can currently be purchased for approximately $0.05.
-
When is SeaStar Medical Holding's next earnings date?
Unfortunately, SeaStar Medical Holding's (ICUCW) next earnings date is currently unknown.
-
Does SeaStar Medical Holding pay dividends?
No, SeaStar Medical Holding does not pay dividends.
-
How much money does SeaStar Medical Holding make?
SeaStar Medical Holding has a market capitalization of 7.11M.
-
What is SeaStar Medical Holding's stock symbol?
SeaStar Medical Holding Corporation is traded on the NASDAQ under the ticker symbol "ICUCW".
-
What is SeaStar Medical Holding's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of SeaStar Medical Holding?
Shares of SeaStar Medical Holding can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does SeaStar Medical Holding have?
As Jul 2024, SeaStar Medical Holding employs 12 workers, which is 33% more then previous quarter.
-
What is SeaStar Medical Holding's official website?
The official website for SeaStar Medical Holding is seastarmedical.com.
-
Where are SeaStar Medical Holding's headquarters?
SeaStar Medical Holding is headquartered at 3513 Brighton Boulevard, Denver, CO.
-
How can i contact SeaStar Medical Holding?
SeaStar Medical Holding's mailing address is 3513 Brighton Boulevard, Denver, CO and company can be reached via phone at +84 44278100.
SeaStar Medical Holding company profile:
SeaStar Medical Holding Corporation
seastarmedical.comNASDAQ
12
Biotechnology
Healthcare
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
Denver, CO 80216
CIK: 0001831868
ISIN: US81256L1127
CUSIP: 81256L112
